Susquehanna International Group, LLP Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $1.81 Million - $1.9 Million	-12,500 Reduced 5.84%	201,500 $30.5 Million
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $5.37 Million - $9.43 Million	-64,600 Reduced 23.19%	214,000 $31.2 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $13.5 Million - $17.5 Million	122,300 Added 78.25%	278,600 $33 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $10.2 Million - $15.1 Million	-102,000 Reduced 39.49%	156,300 $21.5 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $18.2 Million - $25.5 Million	-183,700 Reduced 41.56%	258,300 $35.9 Million
Q2 2021 Aug 11, 2021	BUY	$65.78 - $105.02 $16.8 Million - $26.8 Million	255,100 Added 136.49%	442,000 $42.9 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $13.6 Million - $19.4 Million	-211,800 Reduced 53.12%	186,900 $12.8 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $13.7 Million - $20.7 Million	-210,200 Reduced 34.52%	398,700 $34.2 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $643,536 - $849,655	-10,900 Reduced 1.76%	608,900 $39.6 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $2.49 Million - $6.37 Million	85,800 Added 16.07%	619,800 $45.3 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $2.96 Million - $6.17 Million	107,700 Added 25.26%	534,000 $18.2 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $5.58 Million - $7.87 Million	-136,500 Reduced 24.25%	426,300 $23.2 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $6.35 Million - $8.4 Million	-169,900 Reduced 23.19%	562,800 $23.5 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $18.6 Million - $31.4 Million	467,900 Added 176.7%	732,700 $32.1 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $7.87 Million - $12.1 Million	227,900 Added 617.62%	264,800 $13.6 Million
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $5.05 Million - $7.28 Million	-169,600 Reduced 82.13%	36,900 $1.37 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $757,449 - $993,300	23,100 Added 12.6%	206,500 $7.75 Million
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $3.71 Million - $6.64 Million	-156,900 Reduced 46.11%	183,400 $7.25 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $6.53 Million - $10 Million	290,200 Added 579.24%	340,300 $8.77 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $1.02 Million - $1.78 Million	50,100	50,100 $1.35 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account